Could a sleep drug ward off Alzheimer's? new trial aims to find out
NCT ID NCT07213349
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study tests whether daridorexant, a sleep medication, can help prevent Alzheimer's disease by clearing harmful proteins from the brain. It is open to 240 adults without dementia, even if they don't have sleep problems. Participants will take the drug or a placebo for a period and have their blood and thinking skills monitored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre StoP-Alzheimer (Douglas Mental Health University Institute - Research Centre)
RECRUITINGMontreal, Quebec, H4H 1R3, Canada
Contact
Contact
Conditions
Explore the condition pages connected to this study.